Variant report
Variant | esv3479743 |
---|---|
Chromosome Location | chr8:106796452-106797380 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:106793819..106795349-chr8:106797024..106799447,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-778D12.2.1-4 | chr8:106797232-106797445 | ENSG00000251003.2 |
2 | lnc-RP11-778D12.2.1-4 | chr8:106797219-106797445 | ENSG00000251003.2 |
3 | lnc-RP11-778D12.2.1-4 | chr8:106797283-106797445 | ENSG00000251003.2 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZFPM2 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538976751 | chr8:106796488-106796489 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs111873300 | chr8:106796502-106796503 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs376535033 | chr8:106796533-106796534 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs16873678 | chr8:106796540-106796541 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs542623375 | chr8:106796562-106796563 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs16873680 | chr8:106796618-106796619 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs573304431 | chr8:106796882-106796883 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs371231247 | chr8:106796920-106796921 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs564968359 | chr8:106796967-106796968 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs386728530 | chr8:106796972-106796973 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs577939886 | chr8:106796979-106796980 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs532367960 | chr8:106796982-106796983 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs550858171 | chr8:106797028-106797029 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs143087211 | chr8:106797036-106797037 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs148212476 | chr8:106797061-106797062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181349352 | chr8:106797069-106797070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs566549821 | chr8:106797073-106797074 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184688543 | chr8:106797090-106797091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs117940380 | chr8:106797226-106797227 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs550203447 | chr8:106797289-106797290 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs547148054 | chr8:106797291-106797292 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs7816259 | chr8:106797317-106797318 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs569961744 | chr8:106797325-106797326 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs188190608 | chr8:106797345-106797346 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs7816597 | chr8:106797346-106797347 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs181002325 | chr8:106797350-106797351 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs569214935 | chr8:106797357-106797358 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs536648359 | chr8:106797366-106797367 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs185067277 | chr8:106797368-106797369 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs7834726 | chr8:106797379-106797380 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastric cancer | 22539939 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Prostate cancer | 22341455 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 22522925 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:106782200-106800800 | Weak transcription | K562 | blood |
2 | chr8:106782800-106809000 | Weak transcription | NH-A | brain |
3 | chr8:106783200-106813200 | Weak transcription | Psoas Muscle | Psoas |
4 | chr8:106783200-106813200 | Weak transcription | Right Ventricle | heart |
5 | chr8:106783400-106809000 | Weak transcription | Aorta | Aorta |
6 | chr8:106787600-106809000 | Weak transcription | Ovary | ovary |
7 | chr8:106791800-106813800 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
8 | chr8:106792200-106809400 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
9 | chr8:106792200-106813200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
10 | chr8:106792600-106800600 | Weak transcription | Stomach Smooth Muscle | stomach |
11 | chr8:106792600-106809000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
12 | chr8:106792800-106809000 | Weak transcription | Adipose Nuclei | Adipose |
13 | chr8:106793000-106799000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
14 | chr8:106794200-106800000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr8:106794400-106797200 | Weak transcription | Fetal Heart | heart |
16 | chr8:106794400-106799200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr8:106796200-106796600 | Enhancers | HUVEC | blood vessel |
18 | chr8:106796600-106823600 | Weak transcription | HUVEC | blood vessel |
19 | chr8:106796800-106798000 | Enhancers | Left Ventricle | heart |
20 | chr8:106797200-106797800 | Enhancers | Fetal Heart | heart |